Neurocrine Biosciences (NBIX) Other Operating Expenses (2010 - 2026)
Neurocrine Biosciences (NBIX) reported Other Operating Expenses of $41.1 million for Q2 2026, up 263.7% from $11.3 million a year earlier and up 542.2% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Other Operating Expenses (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Neurocrine Biosciences' Other Operating Expenses came in at $96.4 million, up 130.1% year-over-year; for FY2025, it was $69.5 million, up 49.5% from FY2024.
- Other Operating Expenses has a five-year compound annual growth rate of -16.8% (FY2020 to FY2025).
- By year, Other Operating Expenses came in at $46.5 million in FY2024 (-74.7%), $183.6 million in FY2023 (+691.4%), $23.2 million in FY2022 (-80.6%) and $119.6 million in FY2021 (-31.5%).
- The Q2 2026 figure ranks as the highest quarterly Other Operating Expenses since Q1 2023.
- Year over year, Other Operating Expenses gained in four of the last eight quarters, with growth averaging 57.9%.
- The high point for year-over-year Other Operating Expenses in five years was Q2 2026 (growth of 263.7%); the low point was Q3 2021 (a decline of 96.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.4 million (Q1 2026), $34.6 million (Q4 2025) and $14.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Neurocrine Biosciences | 14.41 Bn | 10.11 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 41.10 Mn |
| Mar 31, 2026 | 6.40 Mn |
| Dec 31, 2025 | 34.60 Mn |
| Sep 30, 2025 | 14.30 Mn |
| Jun 30, 2025 | 11.30 Mn |
| Mar 31, 2025 | 9.30 Mn |
| Dec 31, 2024 | 12.30 Mn |
| Sep 30, 2024 | 9.00 Mn |
| Jun 30, 2024 | 11.70 Mn |
| Mar 31, 2024 | 13.50 Mn |
| Dec 31, 2023 | 8.50 Mn |
| Sep 30, 2023 | 11.20 Mn |
| Jun 30, 2023 | 11.50 Mn |
| Mar 31, 2023 | 152.40 Mn |
| Dec 31, 2022 | 7.70 Mn |
| Sep 30, 2022 | 6.10 Mn |
| Jun 30, 2022 | 4.80 Mn |
| Mar 31, 2022 | 4.60 Mn |
| Dec 31, 2021 | 104.40 Mn |
| Sep 30, 2021 | 4.20 Mn |
API Access
Neurocrine Biosciences Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();